Where does CytoAgents's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across CytoAgents's 2 recorded funding rounds.

Premier Alternatives

CytoAgents

Pittsburgh, PA · Founded 2018 · Privately Held (backing)

Developer of pharmaceutical drugs designed to treat cytokine release syndrome. CytoAgents is based in Pittsburgh, PA and was founded in 2018. It was valued at $52 million at its later-stage round in May 2023, the last priced event on record. It has raised $38.6 million across 2 recorded rounds; the latest was a $7 million early-stage round in May 2023.

PMV mark · valuation

$52.0M

Oct 2026

Priced at

its later-stage round

May 2023

Total raised

$38.6M

Last round

Early Stage VC

May 2023

Cap table — not yet on record

CytoAgents's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of CytoAgents with a free account

·The complete investor list: 15 names
·Watch CytoAgents: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about CytoAgents

Where does CytoAgents's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across CytoAgents's 2 recorded funding rounds.